Across TCGA patient cohorts, BTBD17 mutation is significantly associated with the RNA expression of many other genes, with 106 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible BTBD17-associated genes across cancer lineages are RNU6-1233P, RNA5SP143, and PRY2. Each is linked with BTBD17 in more than 1 cancer types. Because this analysis shows association rather than direction, both BTBD17-to-partner and partner-to-BTBD17 results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (BTBD17→partner) and Y-score (partner→BTBD17) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
BRCA	RNU6-1233P →	+0.614	+5.288	.009	.006	3	2
BRCA	RNA5SP143 →	+0.403	+8.731	<.001	<.001	3	2
LGG	PRY2 →	+0.034	+7.977	<.001	.007	3	2
COAD	OR9Q2 →	+0.097	+6.721	<.001	<.001	3	2
COAD	MIR147A →	+0.874	+5.893	<.001	.002	3	2
SKCM	MIR6881 →	+0.613	+4.310	<.001	.003	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 106 associations by consensus.

Exploration

BTBD17 survival (RNA) · tumor vs normal (RNA) · all BTBD17 data types